DK3600276T3 - Betahistin, eller et farmaceutisk acceptabelt salt deraf og en monoaminoxidase-inhibitor til anvendlese til behandling eller forebyggelse af et eller flere symptomer på svimmelhed hos et individ - Google Patents
Betahistin, eller et farmaceutisk acceptabelt salt deraf og en monoaminoxidase-inhibitor til anvendlese til behandling eller forebyggelse af et eller flere symptomer på svimmelhed hos et individ Download PDFInfo
- Publication number
- DK3600276T3 DK3600276T3 DK18715909.0T DK18715909T DK3600276T3 DK 3600276 T3 DK3600276 T3 DK 3600276T3 DK 18715909 T DK18715909 T DK 18715909T DK 3600276 T3 DK3600276 T3 DK 3600276T3
- Authority
- DK
- Denmark
- Prior art keywords
- monoaminoxidase
- betahistine
- dizziness
- symptoms
- inhibitor
- Prior art date
Links
- UUQMNUMQCIQDMZ-UHFFFAOYSA-N betahistine Chemical compound CNCCC1=CC=CC=N1 UUQMNUMQCIQDMZ-UHFFFAOYSA-N 0.000 title 1
- 229960004536 betahistine Drugs 0.000 title 1
- 208000002173 dizziness Diseases 0.000 title 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1704949.5A GB201704949D0 (en) | 2017-03-28 | 2017-03-28 | Combination treatment |
| GBGB1711677.3A GB201711677D0 (en) | 2017-07-20 | 2017-07-20 | Combination treatment |
| PCT/GB2018/050822 WO2018178670A1 (en) | 2017-03-28 | 2018-03-28 | Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3600276T3 true DK3600276T3 (da) | 2023-07-10 |
Family
ID=61906770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18715909.0T DK3600276T3 (da) | 2017-03-28 | 2018-03-28 | Betahistin, eller et farmaceutisk acceptabelt salt deraf og en monoaminoxidase-inhibitor til anvendlese til behandling eller forebyggelse af et eller flere symptomer på svimmelhed hos et individ |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US11083718B2 (da) |
| EP (2) | EP3600276B1 (da) |
| DK (1) | DK3600276T3 (da) |
| ES (1) | ES2950452T3 (da) |
| FI (1) | FI3600276T3 (da) |
| HR (1) | HRP20230735T1 (da) |
| HU (1) | HUE062729T2 (da) |
| LT (1) | LT3600276T (da) |
| PL (1) | PL3600276T3 (da) |
| PT (1) | PT3600276T (da) |
| RS (1) | RS64304B1 (da) |
| SI (1) | SI3600276T1 (da) |
| SM (1) | SMT202300207T1 (da) |
| WO (1) | WO2018178670A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3600276B1 (en) | 2017-03-28 | 2023-05-31 | IntraBio Ltd | Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject |
| GB201709459D0 (en) | 2017-06-14 | 2017-07-26 | Intrabio Ltd | Treatment for migraine |
| US12145899B2 (en) | 2018-12-06 | 2024-11-19 | Intrabio Ltd. | Deuterated analogs of acetyl-leucine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7728015B2 (en) * | 2004-04-22 | 2010-06-01 | Mor Research Applications Ltd. | Compositions for weight management |
| EA022565B1 (ru) * | 2008-05-27 | 2016-01-29 | Дзе Юниверсити Оф Мельбурн | Способы лечения млекопитающих с дисфункциями евстахиевой трубы |
| EP2491930A1 (en) | 2011-02-25 | 2012-08-29 | Deva Holding Anonim Sirketi | Pharmaceutical combination of betahistine and trimetazidine |
| EP3600276B1 (en) | 2017-03-28 | 2023-05-31 | IntraBio Ltd | Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject |
-
2018
- 2018-03-28 EP EP18715909.0A patent/EP3600276B1/en active Active
- 2018-03-28 SI SI201830944T patent/SI3600276T1/sl unknown
- 2018-03-28 PT PT187159090T patent/PT3600276T/pt unknown
- 2018-03-28 SM SM20230207T patent/SMT202300207T1/it unknown
- 2018-03-28 EP EP23176227.9A patent/EP4234022A3/en active Pending
- 2018-03-28 DK DK18715909.0T patent/DK3600276T3/da active
- 2018-03-28 WO PCT/GB2018/050822 patent/WO2018178670A1/en not_active Ceased
- 2018-03-28 US US16/499,087 patent/US11083718B2/en active Active
- 2018-03-28 PL PL18715909.0T patent/PL3600276T3/pl unknown
- 2018-03-28 ES ES18715909T patent/ES2950452T3/es active Active
- 2018-03-28 LT LTEPPCT/GB2018/050822T patent/LT3600276T/lt unknown
- 2018-03-28 HU HUE18715909A patent/HUE062729T2/hu unknown
- 2018-03-28 HR HRP20230735TT patent/HRP20230735T1/hr unknown
- 2018-03-28 RS RS20230485A patent/RS64304B1/sr unknown
- 2018-03-28 FI FIEP18715909.0T patent/FI3600276T3/fi active
-
2021
- 2021-08-06 US US17/396,064 patent/US11690830B2/en active Active
-
2023
- 2023-05-19 US US18/320,761 patent/US12121513B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL3600276T3 (pl) | 2023-08-21 |
| HUE062729T2 (hu) | 2023-12-28 |
| EP3600276B1 (en) | 2023-05-31 |
| SI3600276T1 (sl) | 2023-08-31 |
| SMT202300207T1 (it) | 2023-09-06 |
| HRP20230735T1 (hr) | 2023-10-13 |
| US11690830B2 (en) | 2023-07-04 |
| US11083718B2 (en) | 2021-08-10 |
| US20210085659A1 (en) | 2021-03-25 |
| EP3600276A1 (en) | 2020-02-05 |
| EP4234022A3 (en) | 2023-10-04 |
| US20230285373A1 (en) | 2023-09-14 |
| PT3600276T (pt) | 2023-07-11 |
| RS64304B1 (sr) | 2023-07-31 |
| US20210361632A1 (en) | 2021-11-25 |
| LT3600276T (lt) | 2023-08-10 |
| WO2018178670A1 (en) | 2018-10-04 |
| US12121513B2 (en) | 2024-10-22 |
| FI3600276T3 (fi) | 2023-06-29 |
| ES2950452T3 (es) | 2023-10-10 |
| EP4234022A2 (en) | 2023-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3870579T3 (da) | Tyk2-inhibitorer og anvendelser deraf | |
| DK3658557T3 (da) | Tyk2-inhibitorer og anvendelser deraf | |
| DK3717636T5 (da) | Adeno-associeret-virus-variantcapsider og anvendelse til inhibering af angiogenese | |
| DK3889145T3 (da) | 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme | |
| DK3009511T3 (da) | Hidtil ukendte crispr-enzymer og systemer | |
| DK3185868T3 (da) | Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme | |
| DK3113764T3 (da) | Farmaceutisk sammensætning til transmukosal afgivelse og fremgangsmåder til behandling af diabetes hos et individ, som har behov derfor | |
| DK3464266T3 (da) | Substituerede indazoler, der er anvendelige til behandling og forebyggelse af allergiske og/eller inflammatoriske sygdomme hos dyr | |
| DK3786160T3 (da) | Pyridinderivater og terapeutiske anvendelser deraf som trpc6-inhibitorer | |
| DK3532459T3 (da) | Lsd1-hæmmere og medicinske anvendelser deraf | |
| DK3692009T3 (da) | Biocementationsfremgangsmåde og system | |
| DK3621694T3 (da) | Lrrc33-inhibitorer og anvendelse heraf | |
| DK3426243T3 (da) | 3-phosphoglyceratdehydrogenase-inhibitorer og anvendelser deraf | |
| DK3362449T3 (da) | Sibirilin-derivater til anvendelse til at forebygge og/eller behandle lidelser associeret med cellulær nekroptose | |
| DK3474883T3 (da) | Komplementinhibitorer og anvendelser deraf | |
| DK3447056T3 (da) | Multikinasehæmmerforbindelse, krystalform og anvendelse deraf | |
| DK3808188T1 (da) | Fiskefoder og fremgangsmåde til smoltifikation og forebyggelse af desmoltifikation hos salmonidae samt til profylakse og behandling af hæmoragisk smoltsyndrom (hss) hos salmonidae | |
| DK3268374T3 (da) | Kv1.3-inhibitorer og deres medicinske anvendelse | |
| HUE058314T2 (hu) | Pridopidin alkalmazása Rett-szindróma kezelésére | |
| DK3310190T3 (da) | Sammensætning til behandling af kød og anvendelse af denne | |
| DK3458650T3 (da) | Fremgangsmåde til desinficering og vandhaneforbindelsesarrangement dertil | |
| DK3720875T3 (da) | Antimikrobielle peptider og fremgangsmåder til anvendelse deraf | |
| DK3919498T6 (da) | Pyrrolopyrimidinderivat og anvendelse deraf | |
| DK3841066T3 (da) | Afsaltningssystem og fremgangsmåde | |
| DK3600276T3 (da) | Betahistin, eller et farmaceutisk acceptabelt salt deraf og en monoaminoxidase-inhibitor til anvendlese til behandling eller forebyggelse af et eller flere symptomer på svimmelhed hos et individ |